Caricamento...
Theoretical Impact of Florbetapir ((18)F) Amyloid Imaging on the Diagnosis of Alzheimer’s Dementia and the Detection of Preclinical Cortical Amyloid
In 2012, florbetapir ((18)F) (Amyvid) received US FDA approval as a diagnostic agent for detecting neuritic (β-amyloid) plaques in live patients. Although such approval is specifically not extended to the usage of florbetapir as a single definitive diagnostic test for Alzheimer disease dementia (ADD...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4169306/ https://ncbi.nlm.nih.gov/pubmed/25192053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/NEN.0000000000000114 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|